ArticleHealth science reports2025
Piccolo Device for Treating Patent Ductus Arteriosus Beyond Premature Newborn Patients, a Novel Experience in South America: A Retrospective Study.
Article in Health science reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Comment On: Piccolo Device for Treating Patent Ductus Arteriosus Beyond Premature Newborn Patients, a Novel Experience in South America: A Retrospective Study.Health science reports · 2026Article
- Piccolo Device for Treating Patent Ductus Arteriosus Beyond Premature Newborn Patients, a Novel Experience in South America: A Retrospective Study.Health science reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aims: Transcatheter closure of patent ductus arteriosus (PDA), particularly with the Amplatzer Piccolo Occluder, offers advantages over surgical closure, including better recovery and lower risk of complications. Although its smaller profile is preferred for neonatal endovascular closure, it may be used in patients of varying ages. This study aims to evaluate the effectiveness of the Piccolo device in PDA treatment beyond premature newborns. Methods: A retrospective study was conducted on patients who underwent PDA closure with the Piccolo device at our institution between January 2021 and December 2023. Results: Twenty-nine patients underwent transcatheter closure with the Piccolo device, with a mean age of 24 months (IQR: 5-23) and a mean weight of 10.4 kg (IQR: 5.6-13.8). The average ductus arteriosus diameter was 1.65 mm (IQR: 1.0-1.9), and the most commonly used device size was 4/4 mm ( Conclusion: These findings suggest a potential extension of the utility of the Piccolo device beyond the neonatal phase, demonstrating its safety and efficacy in older pediatric patients weighing over 2 kg, without a significant increase in complications or mortality rates.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.